| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 72,610 | 60,095 | 37,362 | 70,095 | | Cost of Revenue | 39,572 | 36,288 | 30,431 | 37,663 | | | Gross Profit | 33,038 | 23,807 | 6,931 | 32,432 | | | Operating Expenses | | Research Development | 8,287 | 8,292 | 11,651 | 10,053 | | Selling General and Administrative | 16,713 | 18,706 | 22,240 | 20,955 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,038 | (3,191) | (26,960) | 1,424 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 225 | (285) | (2,146) | 402 | | Earnings Before Interest And Taxes | 8,263 | (3,476) | (29,106) | 1,826 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 8,263 | (3,476) | (29,106) | 1,826 | | Income Tax Expense | 1,724 | (1,732) | (10,682) | (1,374) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,539 | (1,744) | (18,424) | 3,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,539 | (1,744) | (18,424) | 3,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,539 | ($1,744) | ($18,424) | $3,200 |
|
0.31% Nasdaq 0.00%
Income Statement
